COVID-19 was the third leading cause of death in the United States in 2021
COVID-19 was the third leading cause of death in the United States in 2021
A 2021 U.S. mortality data report indicates COVID-19 was the third leading cause of death, following heart disease and cancer. This observat…
In 2021, COVID-19 remained the third leading cause of death in the United States, trailing only heart disease and cancer.
Review explores mitochondrial transfer mechanisms in immune microenvironment remodeling across diseases
Review explores how cells share mitochondria to influence immune responses in disease
A systematic review summarizes emerging evidence on intercellular mitochondrial transfer mechanisms in inflammation, cancer, and autoimmune …
Cells swap energy factories to reshape immune responses in cancer, inflammation, and autoimmune diseases, offering new ways to target these …
Hypoxia in solid tumors drives metabolic reprogramming, immune suppression, and therapeutic resistance
How do tumors survive in low oxygen? They completely change how they eat.
A systematic review synthesizing evidence on hypoxia in solid tumors found that low oxygen tension orchestrates metabolic reprogramming thro…
When tumors run out of oxygen, they switch diets to eat fat and glutamine, becoming more invasive, acidic, and resistant to treatment.
Report describes COVID-19 deaths among US cancer survivors in 2021
How many cancer survivors died with COVID-19 listed as a cause in 2021?
A descriptive report examined deaths among cancer survivors in the United States during 2021 where COVID-19 was listed as an underlying caus…
A 2021 report confirms COVID-19 was a documented cause of death for some cancer survivors, though it lacks specific numbers or comparisons t…
Observational study examines cancer death rates by urban-rural status in US population
Do cancer death rates differ between cities and rural areas?
An observational analysis of US National Vital Statistics System data from 1999-2019 examined age-adjusted cancer death rates by urban-rural…
Where you live might play a role in cancer risk, so a new analysis maps death rates across urban and rural areas for men and women over twen…
Low creatinine-cystatin C ratio correlates with reduced survival in cancer patients in meta-analysis
Could a simple blood test ratio help predict cancer survival?
A meta-analysis of 12 observational trials involving 4439 individuals with cancer found a low creatinine-cystatin C ratio (CCR) was correlat…
A low ratio of two kidney markers in blood is linked to shorter survival and higher risk of cancer progression in people with cancer.
Heart disease and cancer death rates studied in US adults aged 45-64 from 1999 to 2018
U.S. study tracks heart disease and cancer death rates in middle-aged adults
An observational study examined heart disease and cancer death rates among US men and women aged 45-64 years from 1999 to 2018. The specific…
A U.S. study tracked heart disease and cancer death rates in middle-aged adults from 1999 to 2018, but the final results were not reported.
PAI-1 inhibition shows preclinical promise; elevated levels linked to poor cancer prognosis
Could a common cancer protein become a new treatment target?
A systematic review found elevated plasminogen activator inhibitor-1 (PAI-1) levels are consistently associated with poor prognosis across s…
High levels of a protein called PAI-1 signal worse outcomes in several cancers, while early lab studies suggest blocking it could help fight…
Report examines cardiovascular health and predicted heart age in US cancer survivors
Researchers examine cardiovascular health and heart age in US cancer survivors
An observational report describes cardiovascular health and predicted heart age in cancer survivors in the United States. No specific study …
A new report examines predicted heart age among US cancer survivors to understand their cardiovascular health challenges.
Systematic review describes polysaccharide mechanisms and structure-activity relationships for anti-cancer effects
Review explores how natural polysaccharides may work against cancer in lab studies
A systematic review summarizes preclinical research on natural polysaccharides, describing multi-target anti-cancer mechanisms including imm…
Natural plant sugars might fight cancer by boosting immune cells, triggering tumor death, and stopping blood vessel growth in lab tests.
Home treatment for low-risk cancer-associated PE shows 4.6% major bleeding rate in ONCO PE companion report
Could some cancer patients safely treat blood clots at home? New research suggests yes.
A predetermined companion report from the ONCO PE trial evaluated 3-month outcomes for home vs. in-hospital treatment of active cancer patie…
Active cancer patients with low-risk lung clots can safely take blood thinners at home, avoiding disruptive hospital stays while staying on …
Meta-analysis: 42% palliative care utilization among Ethiopian cancer patients; education, male gender associated
In Ethiopia, less than half of cancer patients get the care they need to manage pain and symptoms.
A systematic review and meta-analysis of 9 cross-sectional studies involving 2,839 cancer patients in Ethiopia found a pooled palliative car…
In Ethiopia, only 42% of cancer patients receive pain and symptom relief, with men and educated individuals far more likely to get this esse…